[Weibo (WB US) Target Price Change]: Rebound After Temporary Disturbance, Maintain BUY

[Weibo (WB US) Earnings Review]: Maintain BUY for Ads Recovery in Coming Quarters

Weibo (WB US) – Recovery on the horizon despite ST pressure

China/Asia TMT, Blue Lotus Research Institute

Shawn Yang

China/Asia TMT

China TMT research

Blue Lotus Research Institute

​​​​​​​​Blue Lotus is a China headquartered research institution covering overseas listed China TMT stocks. 

Equity Bottom-Up

<ul>
<li>Weibo’s 1Q23 top line was in line with our est., and non-GAAP net income beat our est./cons. by 6.5%/ 7.6%, due to cost-saving measures. </li>
<li>While we dial down its 2Q23 revenue forecast, we remain optimistic about its growth in 2H23, as more brand advertisers gradually recover. </li>
<li>Maintain BUY and TP unchanged, which implies 12X PE in 2023.</li>
</ul>


Weibo’s 1Q23 top line was in line with our est., and non-GAAP net income beat our est./cons. by 6.5%/ 7.6%, due to cost-saving measures. 
While we dial down its 2Q23 revenue forecast, we remain optimistic about its growth in 2H23, as more brand advertisers gradually recover. 
Maintain BUY and TP unchanged, which implies 12X PE in 2023.


Weibo (WB US, BUY, TP US$26.9) Earnings Review: Maintain BUY for Margin Improvement

Weibo Corp

Weibo (WB US, BUY, TP US$26.9) Earnings Review: Maintain BUY for Margin Improvement